Expression of vitamin D receptor decreases during progression of pigmented skin lesions

Human Pathology

Volumn 42, Issue 5, 2011, Pages 618-631

  Brozyna, Anna A ^a   Jozwicki, Wojciech ^a   Janjetovic, Zorica ^b   Slominski, Andrzej T ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Melanogenesis; Melanoma; Tumor progression; Vitamin D; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; METASTASIS; NEVUS; PIGMENT DISORDER; PROTEIN EXPRESSION; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL NUCLEUS; DISEASE PROGRESSION; ELASTIC TISSUE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANINS; MELANOMA; MIDDLE AGED; MITOSIS; NEVUS, PIGMENTED; PIGMENTATION DISORDERS; RECEPTORS, CALCITRIOL; SKIN; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 79954576002     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.09.014     Document Type: Article

References (48)

1. Holick M., MacLaughlin J.A., and Clark M.B. Photosynthesis of previtamin D3 in human skin and the physiologic consequences Science 210 1980 203 205 (Pubitemid 11252464)
2. Holick M., and Vitamin D. A millenium perspective J Cell Biochem 88 2003 296 307
3. Bikle D.D., Nemanic M.K., Gee E., and Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation J Clin Invest 78 1986 557 566 (Pubitemid 16074095)
4. Lehmann B. Role of the vitamin D3 pathway in healthy and diseased skin-facts, contradictions and hypotheses Exp Dermatol 18 2009 97 108
5. Kramer C., Seltmann H., Seifert M., Tilgen W., Zouboulis C.C., and Reichrath J. Characterization of the vitamin D endocrine system in human sebocytes in vitro J Steroid Biochem Mol Biol 113 2009 9 16
6. Slominski A. Are suberythemal doses of ultraviolet B good for your skin? Pigment Cell Melanoma Res 22 2009 154 155
7. Bikle D.D. Vitamin D: newly discovered actions require reconsideration of physiologic requirements Trends Endocrinol Metab 21 2010 375 384
8. Sutton A.L., and MacDonald P.N. Vitamin D: more than a "bone-a-fide" hormone Mol Endocrinol 17 2003 777 791 (Pubitemid 36539572)
9. DeLuca H.F. Overview of general physiologic features and functions of vitamin D Am J Clin Nutr 80 2004 1689S 1696S
10. Lin R., and White J.H. The pleiotropic actions of vitamin D Bioessays 26 2004 21 28 (Pubitemid 38095345)
11. Bouillon R., Carmeliet G., and Verlinden L. Vitamin D and human health: lessons from vitamin D receptor null mice Endocr Rev 29 2008 726 776
12. Tangpricha V., Spina C., and Yao M. deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice J Nutr 135 2005 2350 2354 (Pubitemid 41429589)
13. Beer T., and Myrthue A. Calcitriol in cancer treatment: from the lab to the clinic Mol Cancer Ther 3 2004 373 381 (Pubitemid 39193713)
14. Slominski A.T., Zmijewski M.A., and Semak I. Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin PLoS One 4 2009 e4309
15. Zbytek B., Janjetovic Z., and Tuckey R.C. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation J Invest Dermatol 128 2008 2271 2280
16. Slominski A., Semak I., and Zjawiony J. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism FEBS J 272 2005 4080 4090 (Pubitemid 41160916)
17. Zmijewski M.A., Li W., and Zjawiony J.K. Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells Steroids 74 2009 218 228
18. Slominski A.T., Janjetovic Z., and Fuller B.E. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity PLoS One e9907 2010 5
19. Janjetovic Z., Tuckey R.C., Nguyen M.N., and Thorpe E.M. Jr Slominski AT. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes J Cell Physiol 223 2010 36 48
20. Campbell M.J., and Adorini L. The vitamin D receptor as a therapeutic target Expert Opin Ther Targets 10 2006 735 748 (Pubitemid 44479981)
21. Colston K., and Colston M.J. Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture Endocrinology 108 1981 1083 1086 (Pubitemid 11142302)
22. Reichrath J., Rech M., Moeini M., Meese E., Tilgen W., and Seifert M. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells Cancer Biol Ther 6 2007 48 55 (Pubitemid 46294175)
23. Gray-Schopfer V., Wellbrock C., and Marais R. Melanoma biology and new targeted therapy Nature 445 2007 851 857
24. Carlson J.A., Ross J.S., and Slominski A. Molecular diagnostics in melanoma J Am Acad Dermatol 52 2005 743 775 (Pubitemid 40614638)
25. Berwick M., Armstrong B.K., and Ben-Porat L. Sun exposure and mortality from melanoma J Natl Cancer Inst 97 2005 195 199 (Pubitemid 40277369)
26. Rigel D.S. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer J Am Acad Dermatol 58 2008 S129 132
27. Randerson-Moor J., Taylor J.C., and Elliott F. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data Eur J Cancer 45 2009 3271 3281
28. Nurnberg B., Graber S., and Gartner B. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients Anticancer Res 29 2009 3669 3674
29. Newton-Bishop J., Beswick S., and Randerson-Moor J. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma J Clin Oncol 27 2009 5439 5444
30. Mocellin S., and Nitti D. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis Cancer 113 2008 2398 2407
31. Slominski A., Ermak G., and Wortsman J. Modification of melanogenesis in cultured human melanoma cells In Vitro Cell Dev Biol Anim 35 1999 564 565 (Pubitemid 30007652)
32. Halsall J.A., Osborne J.E., Potter L., Pringle J.H., and Hutchinson P.E. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma Br J Cancer 91 2004 765 770 (Pubitemid 39141638)
33. Li C., Liu Z., Zhang Z., and Strom S.S. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma J Invest Dermatol 127 2007 276 280 (Pubitemid 46106902)
34. Mitschele T., Diesel B., and Friedrich M. Analysis of the vitamin D system in basal cell carcinomas (BCCs) Lab Invest 84 2004 693 702 (Pubitemid 38715470)
35. Reichrath J., Rafi L., and Rech M. Analysis of the vitamin D system in cutaneous squamous cell carcinomas J Cutan Pathol 31 2004 224 231 (Pubitemid 38230564)
36. Hanahan D., and Weinberg R.A. The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
37. Gould Rothberg B.E., Bracken M.B., and Rimm D.L. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis J Natl Cancer Inst 101 2009 452 474
38. Matusiak D., Murillo G., Carroll R.E., Mehta R.G., and Benya R.V. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon Cancer Epidemiol Biomarkers Prev 14 2005 2370 2376 (Pubitemid 41437839)
39. Menezes R.J., Cheney R.T., and Husain A. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue Cancer Epidemiol Biomarkers Prev 17 2008 1104 1110
40. Tokumoto M., Tsuruya K., Fukuda K., Kanai H., Kuroki S., and Hirakata H. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism Kidney Int 62 2002 1196 1207
41. Guzey M., Kitada S., and Reed J.C. Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer Mol Cancer Ther 1 2002 667 677
42. Slominski A., and Wortsman J. Neuroendocrinology of the skin Endocr Rev 21 2000 457 487
43. Slominski A., Tobin D.J., Shibahara S., and Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation Physiol Rev 84 2004 1155 1228 (Pubitemid 39287950)
44. Slominski A. Neuroendocrine activity of the melanocyte Exp Dermatol 18 2009 760 763
45. Slominski A., Paus R., and Schadendorf D. Melanocytes as "sensory" and regulatory cells in the epidermis J Theor Biol 164 1993 103 120
46. Brozyna A., VanMiddlesworth L., and Slominski A. Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy Int J Cancer 123 2008 1448 1456
47. Slominski A., Zbytek B., and Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells Int J Cancer 124 2009 1470 1477
48. Slominski A., Paus R., and Mihm M.C. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis Anticancer Res 18 1998 3709 3715 (Pubitemid 28564252)